Related Experiment Videos
Retinoids and keratinocyte differentiation in vitro
R Stadler1, R Müller, M Detmar
1Department of Dermatology, University Medical Center Steglitz, Free University of Berlin, FRG.
Dermatologica
|January 1, 1987
Summary
New retinoid compounds show promise for treating skin disorders. Arotinoid acid and arotinoid sulfone demonstrated superior efficacy in vitro, suggesting potential for psoriasis therapy.
Area of Science:
- Dermatology and Molecular Biology
- Retinoid research and keratinocyte differentiation
Background:
- Standard retinoids (etretinate, isotretinoin) are effective for dermatological disorders but have toxicity concerns.
- New synthetic retinoids were developed to improve the activity-to-toxicity ratio.
Purpose of the Study:
- To screen novel monoaromatic and polyaromatic retinoids for their effects on keratinocyte differentiation in vitro.
- To compare the efficacy of these new compounds with currently used retinoids.
Main Methods:
- In vitro screening of etretin, demethyletretin, 13-cis-etretin, arotinoid, arotinoid acid, and arotinoid ethyl sulfone.
- Assessment of effects on keratinocyte differentiation, including inhibition of crosslinked keratins and envelope proteins.
- Evaluation of effects on keratohyalingranule macroaggregate synthesis.
Main Results:
- Third-generation retinoids exhibited higher antikeratinizing potential than second-generation retinoids.
- Arotinoid acid was identified as the most potent derivative, inhibiting keratins and envelope proteins.
- Arotinoid acid and arotinoid sulfone stimulated keratohyalingranule macroaggregate synthesis, unlike arotinoid.
Conclusions:
- Arotinoid acid and arotinoid sulfone show greater potential for psoriasis therapy compared to arotinoid, based on in vitro differentiation data.
- These findings guide the selection of arotinoid derivatives for future clinical studies in psoriasis.